JPS6013717A - 消化器潰瘍治療予防剤 - Google Patents

消化器潰瘍治療予防剤

Info

Publication number
JPS6013717A
JPS6013717A JP58121757A JP12175783A JPS6013717A JP S6013717 A JPS6013717 A JP S6013717A JP 58121757 A JP58121757 A JP 58121757A JP 12175783 A JP12175783 A JP 12175783A JP S6013717 A JPS6013717 A JP S6013717A
Authority
JP
Japan
Prior art keywords
alkylated
fragment
preventive agent
fragments
ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58121757A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0361655B2 (enrdf_load_stackoverflow
Inventor
Masakazu Iwai
岩井　正和
Kazumasa Yokoyama
和正 横山
Tsunekazu Fukushima
恒和 福島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP58121757A priority Critical patent/JPS6013717A/ja
Priority to CA000457425A priority patent/CA1260828A/en
Priority to DE8484107666T priority patent/DE3474672D1/de
Priority to ES533908A priority patent/ES8605378A1/es
Priority to EP84107666A priority patent/EP0131836B1/en
Publication of JPS6013717A publication Critical patent/JPS6013717A/ja
Priority to US06/827,209 priority patent/US4748157A/en
Priority to US07/163,732 priority patent/US4849404A/en
Publication of JPH0361655B2 publication Critical patent/JPH0361655B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP58121757A 1983-07-04 1983-07-04 消化器潰瘍治療予防剤 Granted JPS6013717A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP58121757A JPS6013717A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤
CA000457425A CA1260828A (en) 1983-07-04 1984-06-26 Therapeutic and prophylactic agent for gastrointestinal ulcers
DE8484107666T DE3474672D1 (en) 1983-07-04 1984-07-02 Alkylated fab or fc fragments of human igg, process for their preparation and pharmaceutical compositions
ES533908A ES8605378A1 (es) 1983-07-04 1984-07-02 Un procedimiento para preparar una composicion terapeutica que contiene un fragmento fab o fa alquilado de inmunoglobulina humana.
EP84107666A EP0131836B1 (en) 1983-07-04 1984-07-02 Alkylated fab or fc fragments of human igg, process for their preparation and pharmaceutical compositions
US06/827,209 US4748157A (en) 1983-07-04 1986-02-04 Composition for gastrointestinal ulcers
US07/163,732 US4849404A (en) 1983-07-04 1988-03-03 Therapeutic and prophylactic agent for gastrointestinal ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58121757A JPS6013717A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤

Publications (2)

Publication Number Publication Date
JPS6013717A true JPS6013717A (ja) 1985-01-24
JPH0361655B2 JPH0361655B2 (enrdf_load_stackoverflow) 1991-09-20

Family

ID=14819129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58121757A Granted JPS6013717A (ja) 1983-07-04 1983-07-04 消化器潰瘍治療予防剤

Country Status (1)

Country Link
JP (1) JPS6013717A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
JPH0361655B2 (enrdf_load_stackoverflow) 1991-09-20

Similar Documents

Publication Publication Date Title
Irvine et al. Immunological relationship between pernicious anaemia and thyroid disease
Bearn Wilson's disease: an inborn error of metabolism with multiple manifestations
Krikler Paracetamol and the kidney
JPH03366B2 (enrdf_load_stackoverflow)
US4748157A (en) Composition for gastrointestinal ulcers
US4985248A (en) Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
US6083931A (en) Method of inhibiting cancer metastasis
JPS6314728A (ja) 肝障害の予防、治療剤
Shanbrom et al. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate
Somayaji et al. Norethisterone jaundice in two sisters
JPS62255430A (ja) 哺乳動物の脈管病を治療する方法
JPS6013717A (ja) 消化器潰瘍治療予防剤
EP0059346B1 (en) Therapeutic agent containing a human urinary pepsin
JPH0148249B2 (enrdf_load_stackoverflow)
JPS6013716A (ja) 消化器潰瘍治療予防剤
THAYER et al. The development of the nephrotic syndrome during the course of congestive heart failure: case report and review of the literature
JPS6238329B1 (enrdf_load_stackoverflow)
JPS5920223A (ja) 肥満防止剤
JPS6237612B2 (enrdf_load_stackoverflow)
Begg Sulphaemoglobinaemia
Rich The Gordon Wilson Lecture. Visceral Hazards of Hypersensitivity to Drugs
JPH03851B2 (enrdf_load_stackoverflow)
JPS5927326B2 (ja) 抗腫瘍活性を有する薬剤組成物
JPS58225026A (ja) アミラ−ゼ活性および／またはリパ−ゼ活性亢進に起因する疾患の予防および治療剤
SU1284553A1 (ru) Способ лечени хронического гломерулонефрита нефротического типа